The Travel Vaccine Market Will Grow Steadily During the Forecast Period 2015 – 2021 – Healthcare Sector

Health-related complications are more important in developing countries and in rural areas because of differences in sanitary conditions, available foods, and water bases. The Advisory Committee on Immunization Practices of the Center for Disease Control and Prevention (CDC) mentions that travelers should be aware of routine vaccinations, regardless of travel plans.

Travel vaccines for the prevention of hepatitis A, hepatitis B, yellow fever, tetanus, polio, meningococcal disease, typhoid fever are manufactured by the main market players to know Sanofi Pasteur, Merck, Novartis and GlaxoSmithKline. Among these companies, Sanofi Pasteur and GSK are notable players in the travel vaccine market, which accounts for around 85% of the total market.

A sample of this report is available on request @ https: // www. persistencemarketresearch.com/samples/5753

Recently in March 2014, Sanofi Pasteur, Sanofi's vaccines segment announced its long-term strategic collaboration with SK Chemicals Company to develop a pneumococcal conjugate vaccine (PCV).

Growth factors in this market include awareness of vaccine-preventable diseases and the increase in global travel traffic.

In addition, the innovation of new vaccine technologies and technological advances towards molecular genetics will stimulate market growth in the years to come. However, the requirement of expertise for vaccine production and unfavorable funding for vaccination could pose a challenge to the growth of this market.

Geographically, North America will be the world's largest market for vaccines, followed by Europe and Asia. Pacific

The main factors contributing to market dominance in North America include the participation of a large number of companies in the production of vaccines and the introduction of a higher range of vaccines on the market. However, the Asia-Pacific market is expected to grow at a significant growth rate in the coming years.

Request a Report Toc @ https://www.persistencemarketresearch.com/toc/5753

The players in this market include GlaxoSmithKline, Sanofi Pasteur, Merck, Novartis and Pfizer. The other main participants in this market are ALK – Abelló A / S, Bavarian Nordic A / S, Crucell N.V., CSL Ltd. Medimmune Inc. and Vaxin Inc.

Posting Publication:
3